DAX+2,63 % EUR/USD-0,16 % Gold-0,83 % Öl (Brent)+0,99 %

MYM Nutraceuticals Inc. - My Marijuana Canada Inc. - Die letzten 30 Beiträge

Beitrag schreiben

Begriffe und/oder Benutzer


Also es ist schade das keine News kommen oder irgendein Statment
...und wieder keine Lizenz!
der Chart wurde vorbildlich abgearbeitet, damit ist ein Rückfall auf ca. .32€cent in den kommenden Tagen zu erwarten....:keks:
News zu Australien

VANCOUVER, British Columbia, December 26, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or “The Company”) announces that the Company is exploring other potential partnerships and will not be proceeding with the project with Australia-based Solaris Nutraceuticals and the proposed Casino, New South Wales, production facility. In furtherance of this, Solaris is in the process of deregistering the company. The shareholders of Solaris, including MYM, determined that deregistration was the best way to move forward allowing MYM and others to pursue other exciting projects and opportunities in Australia.
“MYM determined based on the structure of the transaction and our minority interest in the Solaris deal, that it was not in our best interest to proceed with our current partners”, said Rob Gietl, CEO of MYM. “We are committed to becoming a global player and expanding our business into Australia. Our recent announcement stating we’ve entered into a conditional agreement with Sunmark Growth speaks to this fact. We believe that legalization barriers will be softened around the globe with Australia being a prime candidate for reform. MYM will be there when these changes occur to take full advantage of new business opportunities”.

und schon wieder runter unter 0,30 cent in den kommenden tagen....:keks:
Hab auch schon geforscht, aber nichts gefunden.
Gestern ist auch HC ohne Änderung geupdated worden...
Wie ist den der Sprung gestern kurz vor Ende zu erklären?
Ps: neue Baustellenbilder...die waren es wohl ehr nicht oder?
Bitte schön....


stetig aktualisieren, dann wirst du es mit als erster erfahren....
Hat jemand Informationen warum der Kurs gerade gen Süden geht?
Antwort auf Beitrag Nr.: 58.952.289 von Nosleep am 13.10.18 21:34:47Ich für meinen Teil halte noch ein paar Aktien. Den Großteil bei 3,2€ verkauft. Denke wenn die Produktion läuft macht die Aktie noch einen ordentlichen Sprung nach oben:D
Antwort auf Beitrag Nr.: 58.711.390 von Stecool am 16.09.18 13:22:57
Neue Fotos von der Baustelle
Zitat von Stecool: Baustelle sieht ja auch sehr gross aus...

Mal schauen wie lange es dauert bis Etappe 1 fertig ist.

Antwort auf Beitrag Nr.: 58.628.211 von Nosleep am 06.09.18 08:17:26Baustelle sieht ja auch sehr gross aus...

Mal schauen wie lange es dauert bis Etappe 1 fertig ist.
MYM Announces Closing of Non-Brokered Private Placement
Da will anscheinend ein Millionär ein Multimillionär werden mit dieser Investition! :)

MYM Announces Closing of Non-Brokered Private Placement


VANCOUVER, British Columbia / TheNewswire / September 14, 2018 - MYM Nutraceuticals Inc., (cse:MYM) MYMMF, +0.01% ("MYM") is pleased to announce it has closed a non-brokered private placement consisting of 5,885,972 units at a price of $0.90 per unit for gross proceeds of $5,297,374.80.

Each unit in the private placement is comprised of one common share and one transferable share purchase warrant with each warrant exercisable into one additional common share at a price of $1.50 for a period of two years. The warrants are subject to an acceleration provision that allows the Company to give notice of an earlier expiry date if the Company's share price on the Canadian Securities Exchange (or such other stock exchange the Company may be trading on) is equal or greater than $2.50 for 10 consecutive trading days. The securities will be subject to a four month and one day hold period under securities laws.

In connection with the private placement, the Company paid certain arm's length finders Finder's fees totaling $188,450.46.

The Company intends to use approximately $4,000,000 of the net proceeds from the private placement for the construction of the Weedon Project located in Weedon, Quebec and the remaining funds for general working capital and corporate purposes.
Hemp Stocks Could Be the Next Big Cannabis Trend
MYM Nutraceuticals (CSE:MYM) – $1.22

MYM Nutraceuticals is cannabis producer with operations in Canada and Australia. The Company has two production projects in Quebec, Canada, which will have production space of 1,537,000 sq. ft. in total upon completion in 2020. The combined production capacity is estimated at 187,000 Kg of cannabis annually. MYM also has a production facility of 1,200,000 sq. ft under development in New South Wales, Australia. Its MJT manufacturing project, located in Toronto, is focused on the production of CBD extracts and isolates. The Company’s portfolio brands include CBD products such as HempMed, Joshua Tree and Dr. Furbaby.

Market Cap: $124.9 Million

Eine interessante Aktienanalyse!
Volume Moving the Tape For Mym Nutraceuticals Inc (MYMMF)
Posted by Caroline Biscotti on July 27, 2018 at 3:33 pm

Shares of Mym Nutraceuticals Inc (MYMMF) have seen the needle move -1.69% or -0.015 in the most recent session. The OTC listed company saw a recent bid of $0.8750 on 76853 volume.

Many investors may strive to be in the stock market when the bulls are running and out of the market when the bears are in charge. Investors often use multiple strategies when setting up their portfolios. Some may rely solely on fundamental analysis, technical analysis, or a combination of both. Investing can be an extremely tough process. Individual investors often strive to gather and analyze vast amounts of information in order to make educated decisions. Often times, investors may have initial success in the stock market, and then things may turn sour. Confidence may be necessary to make the tougher decisions, but overconfidence may lead to an underperforming portfolio. Overconfidence may cause the investor to make poor decisions because they are relying too heavily on personal interpretations.

Another technical indicator that may be a powerful resource for determining trend strength is the Average Directional Index or ADX. The ADX was introduced by J. Welles Wilder in the late 1970’s and it has stood the test of time. The ADX is typically used in conjunction with the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to help spot trend direction as well as trend strength. At the time of writing, the 14-day ADX for Mym Nutraceuticals Inc (MYMMF) is noted at 20.65. Many technical analysts believe that an ADX value over 25 would suggest a strong trend. A reading under 20 would indicate no trend, and a reading from 20-25 would suggest that there is no clear trend signal.

Mym Nutraceuticals Inc (MYMMF) currently has a 14-day Commodity Channel Index (CCI) of -111.49. Active investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the flip side, a reading below -100 may signal a downtrend reflecting weak price action. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal.

Digging deeping into the Mym Nutraceuticals Inc (MYMMF) ‘s technical indicators, we note that the Williams Percent Range or 14 day Williams %R currently sits at -91.67. The Williams %R oscillates in a range from 0 to -100. A reading between 0 and -20 would point to an overbought situation. A reading from -80 to -100 would signal an oversold situation. The Williams %R was developed by Larry Williams. This is a momentum indicator that is the inverse of the Fast Stochastic Oscillator.

Investors are paying close attention to shares of Mym Nutraceuticals Inc (MYMMF). A popular tool among technical stock analysts is the moving average. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a specific period of time. Moving averages can be very useful for identifying peaks and troughs. They may also be used to help the trader figure out proper support and resistance levels for the stock. Currently, the 200-day MA is sitting at 1.61, and the 50-day is 1.11.

With the stock market continuing to move higher, investors may be searching for stocks that are still fairly undervalued. This may involve doing a little bit more homework than usual. Spotting those names that have been cast aside and not garnering much recent attention might be a good place to start. Putting in a few extra hours of stock research may provide some good options for buying on the next big dip. Of course, nobody can say for sure how long the markets will continue to climb. Being ready for a pullback can help if investors already have some names in mind that they are looking to scoop up when they fall to a certain level. Tracking the technicals and staying up on the fundamentals should help investors hone in on the next wave of stocks to add to the portfolio.

The RSI, or Relative Strength Index, is a widely used technical momentum indicator that compares price movement over time. The RSI was created by J. Welles Wilder who was striving to measure whether or not a stock was overbought or oversold. The RSI may be useful for spotting abnormal price activity and volatility. The RSI oscillates on a scale from 0 to 100. The normal reading of a stock will fall in the range of 30 to 70. A reading over 70 would indicate that the stock is overbought, and possibly overvalued. A reading under 30 may indicate that the stock is oversold, and possibly undervalued. After a recent check, the 14-day RSI for Mym Nutraceuticals Inc is currently at 31.20, the 7-day stands at 19.84, and the 3-day is sitting at 7.33.

When dealing with the stock market, investors may seek to make trades that will limit regret and create a sense of pride. Often times, investors may be challenged with trying to figure out the proper time to sell winners or let go of losers. Of course, nobody wants to sell a winner if it looks like there may be more profits to be had. On the other hand, nobody wants to hold on to a loser for so long that severe losses pile up. Investors often need to assess their own appetite for risk. Some may be able to stomach large swings on a daily basis. Others may not be able to take the volatility when dealing with riskier investments. Risk decisions may be made on past outcomes, and investors who have experienced previous profits and gains may be more likely to take a bigger risk in the future. Those who have only seen substantial losses may be more risk adverse in the future.

Antwort auf Beitrag Nr.: 58.236.600 von Nosleep am 17.07.18 20:41:52Außer Marapharm ist eigentlich alles was bekannt ist wieder handelbar. Und Marapharm will ja wh keiner.

Viel Aufregung um nichts.
Antwort auf Beitrag Nr.: 58.231.557 von praesens am 17.07.18 12:18:50
Zitat von praesens: ... nicht mehr lange glaube ich.

Gruß, praesens

Mym weiter Handelbar:D
Antwort auf Beitrag Nr.: 58.230.339 von AktiesuchtBauer am 17.07.18 10:05:52... nicht mehr lange glaube ich.

Gruß, praesens
Cannabis und Marijuana Aktien, aktuell die Geld Vernichtungs- Branche ???

"MYM to Acquire 49% Stake in Colombian Cannabis Company, Colombia Organica
C.MYM | 23 hours ago
Canada NewsWire

VANCOUVER, July 10, 2018

VANCOUVER, July 10, 2018 /CNW/ - MYM Nutraceuticals Inc., (CSE: MYM) (OTC:MYMMF)(CSE: MYM.CN) (MYM.CN) ("MYM") is pleased to announce that it has entered into an Investment Agreement to acquire a 49% stake in Colombian cannabis company, Colombia Organica, that currently holds a seed to sale license for low THC cannabis. This license permits Colombia Organica to grow, produce and create cannabis derivatives to be commercialized and / or exported. Further, Colombia Organica is in the licensing process for the cultivation and production of high THC cannabis extracts.

MYM and Colombia Organica have plans to build a production facility near Medellin, Colombia for the cultivation and processing of cannabis and cannabis products. Currently, Colombia Organica is developing and registering seed strains with the Colombian Agricultural Institute.

Colombia Organica currently holds a lease for a 36-acre (14.5 hectares) property located 44 kms from Medellin in the Municipality of San Pedro de los Milagros, in the Northern Region of the Aburra Valley. The region's growing conditions are conducive for growing cannabis with an average temperature of 16-18 °C, and an elevation of 2,475 meters above sea-level. Colombia Organica has secured an option to buy the property.

"We are extremely pleased to partner with our new friends at Colombia Organica," said Rob Gietl, CEO of MYM. "With low production costs expected to be less than 20 cents per gram versus Canadian producers at $1.25 per gram or higher, ideal climate, and a large pool of skilled, low cost agricultural labour, highly developed logistic chains, and a highly supportive federal government, Colombia is anticipated to dominate global markets for cannabis production."

The International Board for the Control of Narcotics recently assigned Colombia a quota equal to 44% of global medicinal cannabis production, giving Colombia a major advantage in the global export market. MYM and Colombia Organica plan to leverage Colombia's outside quotas to export cannabis derivatives for medicinal purposes to legal markets throughout the world.

In exchange for CDN $2,500,000, MYM will acquire 49% of the share capital of Colombia Organica and hold 50% of the voting shares. The purchase price will be disbursed to Colombia Organica as follows: (1) CDN$650,000 upon verification of Colombia Organica's licenses, permits, quotas, and seed registrations, and the details of the property upon which the facility will be constructed; (2) CDN $650,000 on September 1, 2018, provided that MYM has reviewed and approved of the budget for the construction of Colombia Organica's production facility, including greenhouses, irrigation, lights, equipment and physical barriers; and (3) the balance of the purchase price through MYM's purchase of equipment for the facility, as pre-approved by Colombia Organica.

The Investment Agreement further provides that MYM and Colombia Organica both agree to use their best efforts to raise and/or arrange financing of up to CDN $15,000,000 to finance the further build-out of the production facility, including construction of greenhouses, purchase of extraction equipment, and infrastructure development.

A finder's fee equal to 6.5% of the aggregate purchase price will be paid in connection with the transaction.

The Investment Agreement is subject to all required approvals and MYM's due diligence.

About Colombia Organica

Colombia Organica is a Colombian company with expertise in the manufacture of pharmaceutical products, medicinal chemical substances and botanical products. The Company holds a seed to sale license for low THC cannabis and is in the application process for both high THC cannabis cultivation and extraction. Colombia Organica has selected for production high quality plants which are suited to the unique high altitude, equatorial regions of Antioquia, Colomb


Beitrag zu dieser Diskussion schreiben